Furthermore, statins were associated with substantially reduced risk of CV death, all-cause death and 3P-MACE after adjusting for gender, age, diabetic nephropathy, BMI, receiving beta blockers, hs-CRP, and LDL-C level. Here, CRP is linked to diabetic kidney disease.